A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

Completed

Conditions studied: Retinal Vein Occlusion, Macular Edema

In brief

This retrospective data review study will evaluate anti-VEGF injections for retinal vein occlusion (RVO) or diabetic macular edema (DME).

Key facts

Study ID

NCT01918371

Run by

Allergan

People needed

323

Starts

2013-08-02

Expected to finish

2014-09-04

Last updated by the study team

2019-04-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Macular edema in the study eye due to RVO or DME
• Received an anti-VEGF injection in the study eye on or after June 2010 for RVO and on or after August 2012 for DME

You may not qualify if…

• None

Where it is running

• Study site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.